1 – 10 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The Applicability of Mouse Models to the Study of Human Disease
(
- Contribution to journal › Article
-
Mark
Preclinical evidence for the role of stem/stromal cells in COPD
2019) p.73-96(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2018
-
Mark
Effects of 5-Hydroxytryptamine Class 2 Receptor Antagonists on Bronchoconstriction and Pulmonary Remodeling Processes
(
- Contribution to journal › Article
-
Mark
Uncontrolled asthmatics have increased FceRI+ and TGF-β–positive MCTC mast cells and collagen VI in the alveolar parenchyma
(
- Contribution to journal › Article
-
Mark
Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT2B receptor antagonists in vitro - A potential pathway affecting proliferation
(
- Contribution to journal › Article
- 2016
-
Mark
Aberrant nonfibrotic parenchyma in idiopathic pulmonary fibrosis is correlated with decreased β-catenin inhibition and increased Wnt5a/b interaction
(
- Contribution to journal › Article
-
Mark
5-HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo
(
- Contribution to journal › Article
-
Mark
Nemo-like kinase regulates the expression of vascular endothelial growth factor (VEGF) in alveolar epithelial cells
(
- Contribution to journal › Article
- 2015
-
Mark
Versican in inflammation and tissue remodelling: the impact on lung disorders.
(
- Contribution to journal › Scientific review
-
Mark
ROS-induced endothelial stress contributes to pulmonary fibrosis through pericytes and Wnt signaling.
2015) In Laboratory Investigation(
- Contribution to journal › Article